While it it's too early to judge the success of Kaiser Permanente's Risant Health, the company's first two acquisitions show a commitment to adjoining organizations with a strong focus on population health — as well as a dedication to spreading Kaiser's value-based care delivery models across the country.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means. Learn More.
INVEST Digital Health conference is a platform for healthcare industry leaders, innovators, and investors to exchange ideas, explore emerging technologies, and collaborate on solutions that will transform healthcare.
Join us at Pegasus Park, Dallas on September 18 and contribute to thought-provoking conversations.
Blue Shield of California unveiled its new Member Health Record on Wednesday. It allows members to access their health information in one place within the insurer's app or website.
Verona Pharma's COPD drug Ohtuvayre is a single small molecule that blocks two targets to bring patients both bronchodilation and anti-inflammatory effects. Verona executives contend their inhalable drug has key advantages over the last novel COPD medication, the orally administered roflumilast.
It is crucial that we preserve the unique public-private partnership framework that drives innovation in our country by ensuring that the Bayh-Dole Act remains intact.
In this episode, we're joined by John Auerbach, senior vice president of federal health at consulting firm ICF. He discusses rising preeclampsia rates and how stakeholders need to act.
No comments